Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation

Journal of Pharmaceutical Sciences

Volumn 93, Issue 11, 2004, Pages 2851-2862

  Di Colo, Giacomo ^a   Burgalassi, Susi ^a   Zambito, Ylenia ^a   Monti, Daniela ^a   Chetoni, Patrizia ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Absorption enhancer; Cell culture; in vitro models; in vitro in vivo correlations; Mucosal delivery; N trimethyl chitosan; Ocular drug delivery; Ofloxacin; Permeability; Polymeric biomaterials

Indexed keywords

CHITOSAN; DIETHYLAMINOETHYLDEXTRAN; OFLOXACIN;

ANIMAL CELL; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG PENETRATION; DRUG TRANSPORT; ENDOPHTHALMITIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; RABBIT;

EID: 8644259904     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20197     Document Type: Article

References (31)

1. Artursson P, Lindmark T, Davis SS, Illum L. 1994. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 11:1358-1361.
2. Lueßen HL, Rentel CO, Kotzé AF, Lehr CM, de Boer AG, Verhoef JC, Junginger HE. 1997. Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. J Controlled Release 45:15-23.
3. Lueßen HL, de Leeuw BJ, Langemeyer MW, de Boer AB, Verhoef JC, Junginger HE. 1996. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm Res 13:1668-1672.
4. Borchard G, Lueßen HL, de Boer AG, Verhoef JC, Lehr CM, Junginger HE. 1996. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J Controlled Release 39:131-138.
5. Illum L, Farraj NF, Davis SS. 1994. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res 11:1186-1189.
6. Di Colo G, Zambito Y, Burgalassi S, Nardini I, Saettone MF. 2004. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically sapplied ofloxacin. Int J Pharm 273: 37-44.
7. Sieval AB, Thanou M, Kotzé AF, Verhoef JC, Brussee J, Junginger HE. 1998. Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride. Carbohyd Polym 36: 157-165.
8. Singla AK, Chawla M. 2001. Chitosan: Some pharmaceutical and biological aspects - An update. J Pharm Pharmacol 53:1047-1067.
9. Kotzé AF, Lueßen HL, De Leeuw BJ, De Boer AG, Verhoef JC, Junginger HE. 1997. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2). Pharm Res 14: 1197-1202.
10. Kotzé AF, Lueßen HL, De Leeuw BJ, De Boer AG, Verhoef JC, Junginger HE. 1998. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Controlled Release 51:35-46.
11. Thanou M, Florea BI, Langemeyer MWE, Verhoef JC, Junginger HE. 2000. N-trimethyl chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats). Pharm Res 17:27-31.
12. Schipper GM, Olsson S, Hoogstraate JA, De Boer AG, Varum KM, Artusson P. 1997. Chitosan as absorption enhancer for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm Res 14:923-929.
13. Kotzé AF, Thanou M, Lueßen HL, De Boer AG, Verhoef JC, Junginger HE. 1999. Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). Eur J Pharm Biopharm 47:269-274.
14. Hamman JH, Schultz CM, Kotzé AF. 2003. N-trimethyl chitosan chloride: Optimum degree of quaternization for drug absorption enhancement across epithelial cells. Drug Dev Ind Pharm 29: 161-172.
15. Domard A, Rinaudo M, Terrassin C. 1986. New method for the quaternization of chitosan. Int J Biol Macromol 8:105-107.
16. Hamman JH, Kotzé AF. 2001. Effect of the type of base and number of reaction steps on the degree of quaternization and molecular weight of N-trimethyl chitosan chloride. Drug Dev Ind Pharm 27:373-380.
17. Yang YW, Yang JC. 1997. Studies of DEAE-dextran-mediated gene transfer. Biotechnol Appl Biochem 25:47-51.
18. Mack KD, Wei R, Elbagarri A, Abbey N, McGrath MS. 1998. A novel method for DEAE-dextran mediated transfection of adherent primary cultured human macrophages. J Immunol Methods 211: 79-86.
19. Gregory LG, Harbottle RP, Lawrence L, Knapton HJ, Themis M, Coutelle C. 2003. Enhancement of adenovirus-mediated gene transfer to the airways by DEAE dextran and sodium caprate in vivo. Mol Ther 7:19-26.
20. Zambito Y, Baggiani A, Carelli V, Serafini MF, Di Colo G. 2004. Methyl-DEAE-dextran: A candidate biomaterial. Bio-Med Mater Eng, in press.
21. Khalid MN, Ho L, Agnely F, Grossiord JL, Couarraze G. 1999. Swelling properties and mechanical characterisation of a semi-interpenetrating chitosan/polyethylene oxide network. Comparison with a chitosan reference gel. STP Pharma Sci 9: 359-364.
22. Di Colo G, Zambito Y, Burgalassi S, Serafini A, Saettone MF. 2002. Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). Int J Pharm 248:115-122.
23. Burgalassi S, Chetoni P, Monti D, Saettone MF. 2001. Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. Toxicol Lett 122:1-8.
24. Huhtala A, Alajuuma P, Burgalassi S, Chetoni P, Diehl H, Engelke M, Marselos M, Monti D, Pappas P, Saettone MF, Salminen L, Sotiropoulou M, Tahti H, Uusitalo H, Zorn-Kruppa M. 2003. A collaborative evaluation of the cytotoxicity of two surfactants by using the human corneal epithelial cell line and the WST-1 test. J Ocular Pharmacol Ther 19: 11-21.
25. Di Colo G, Zambito Y. 2002. A study of release mechanism of different ophthalmic drugs from erodible ocular inserts based on poly(ethylene oxide). Eur J Pharm Biopharm 54:193-199.
26. Bottari F, Di Colo G, Nannipieri E, Saettone MF, Serafini MF. 1975. Evaluation of a dynamic permeation technique for studying drug-macromolecule interactions. J Pharm Sci 64:946-949.
27. Taravella MJ, Balentine J, Young DA, Stepp P. 1999. Collagen shield delivery of ofloxacin to the human eye. Cataract Refract Surg 25:562-565.
28. Snyman D, Hamman JH, Kotze AF. 2003. Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride. Drug Dev Ind Pharm 29:61-69.
29. Snyman D, Hamman JH, Kotze JS, Rollings JE, Kotzé AF. 2002. The relationship between the absolute molecular weight and the degree of quaternisation of N-trimethyl chitosan chloride. Carbohyd Polym 50:145-150.
30. Ross DL, Riley CM. 1990. Aqueous solubilities of variously substituted quinolone antimicrobials. Int J Pharm 63:237-250.
31. Di Colo G, Burgalassi S, Chetoni P, Fiaschi MP, Zambito Y, Saettone MF. 2001. Gel-forming erodible inserts for ocular controlled delivery of ofloxacin. Int J Pharm 215:101-111.